Aziyo Biologics Revenue and Competitors

Location

$44.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Aziyo Biologics's estimated annual revenue is currently $28.7M per year.(i)
  • Aziyo Biologics received $10.0M in venture funding in August 2018.
  • Aziyo Biologics's estimated revenue per employee is $192,450
  • Aziyo Biologics's total funding is $44.1M.

Employee Data

  • Aziyo Biologics has 149 Employees.(i)
  • Aziyo Biologics grew their employee count by -10% last year.

Aziyo Biologics's People

NameTitleEmail/Phone
1
VP-SalesReveal Email/Phone
2
EVP and General Manager, Musculoskeletal ProductsReveal Email/Phone
3
VP SalesReveal Email/Phone
4
EVP, Operations & Product DevelopmentReveal Email/Phone
5
VP, FinanceReveal Email/Phone
6
National Account DirectorReveal Email/Phone
7
Director, Quality and Regulatory AffairsReveal Email/Phone
8
Director Quality Assurance and Regulatory AffairsReveal Email/Phone
9
Marketing DirectorReveal Email/Phone
10
Senior Director QualityReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M20%N/AN/A
#2
$3.6M46-31%$17.5MN/A
#3
$3.6M46-34%$10.5MN/A
#4
$30.2M1560%$69.4MN/A
#5
$11.8M76-15%N/AN/A
#6
$1.7M110%N/AN/A
#7
$2.5M160%N/AN/A
#8
$8.8M5719%N/AN/A
#9
$0.2M1-86%N/AN/A
#10
$2M1318%N/AN/A
Add Company

What Is Aziyo Biologics?

Aziyo Biologics is a fully integrated, commercially oriented regenerative medicine company. Since its founding in 2015 the Company has expanded through acquisitions and strategic partnerships, creating a high growth commercial entity. Its proprietary products are used in orthopedic, cardiovascular and other medical specialties.

keywords:N/A

$44.1M

Total Funding

149

Number of Employees

$28.7M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aziyo Biologics News

2022-04-06 - Aziyo Biologics Announces Upcoming KOL Call Hosted by ...

SILVER SPRING, Md., April 12, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine...

2022-03-30 - Aziyo Announces FDA 510(k) Submission for CanGaroo® RM ...

Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and...

2022-03-30 - Aziyo Biologics to Participate in the Lytham Partners Spring ...

SILVER SPRING, Md., March 31, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine...

2018-08-07 - Biotech Startup Aziyo Nearly Doubles Its Funding Total With a $10M Raise

Maryland’s health tech startup ecosystem is at it again. Silver Spring-based Aziyo Biologics Inc. has raised $10 million from seven investors in a funding round disclosed Tuesday in SEC filings. Founded in 2015, Aziyo is a private, commercially-oriented biotech company focused on regenerative ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$54M152-7%N/A
#2
$25M157-9%N/A
#3
$39.7M15918%N/A
#4
$7.5M16315%N/A
#5
$33.3M16817%N/A

Aziyo Biologics Funding

DateAmountRoundLead InvestorsReference
2018-08-08$10.0MUndisclosedMulitpleArticle